NDC11 00003229111
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00003-2291-11 | 00003-2291 |
| 0003-2291-11 | 0003-2291 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EMPLICITI | ELOTUZUMAB | E.R. Squibb & Sons, L.L.C. | 80686b7e-f6f4-4154-b5c0-c846425e2d91 | 2022-03-22 | Warnings, Adverse reactions | 0003-2291-11 0003-2291 00003229111 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.